Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32796618)

  • 1. Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics.
    Lo YL; Wang CS; Chen YC; Wang TY; Chang YH; Chen CJ; Yang CP
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32796618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.
    Lo YL; Chang CH; Wang CS; Yang MH; Lin AM; Hong CJ; Tseng WH
    Theranostics; 2020; 10(15):6695-6714. PubMed ID: 32550898
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer.
    Lo YL; Lin HC; Tseng WH
    Acta Biomater; 2022 Nov; 153():465-480. PubMed ID: 36115656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression.
    Wang CS; Chang CH; Tzeng TY; Lin AM; Lo YL
    Nanoscale Horiz; 2021 Sep; 6(9):729-743. PubMed ID: 34323910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.
    Lo YL; Wang TY; Chen CJ; Chang YH; Lin AM
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
    Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
    J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
    Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
    Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
    Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J
    Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
    Devulapally R; Sekar TV; Paulmurugan R
    Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
    Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
    Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.
    Xie Y; Wang Y; Li J; Hang Y; Jaramillo L; Wehrkamp CJ; Phillippi MA; Mohr AM; Chen Y; Talmon GA; Mott JL; Oupický D
    Theranostics; 2018; 8(16):4305-4320. PubMed ID: 30214622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
    Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
    Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375.
    Yang T; Zhao P; Rong Z; Li B; Xue H; You J; He C; Li W; He X; Lee RJ; Ma X; Xiang G
    Theranostics; 2016; 6(1):142-54. PubMed ID: 26722380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Nanocarrier-Based Mitochondrial Chaperone, TRAP-1 Inhibitor to Combat Cancer Metabolism.
    Amash V; Paithankar K; Dharaskar SP; Arunachalam A; Amere Subbarao S
    ACS Appl Bio Mater; 2020 Jul; 3(7):4188-4197. PubMed ID: 35025420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4.
    Sandbothe M; Buurman R; Reich N; Greiwe L; Vajen B; Gürlevik E; Schäffer V; Eilers M; Kühnel F; Vaquero A; Longerich T; Roessler S; Schirmacher P; Manns MP; Illig T; Schlegelberger B; Skawran B
    J Hepatol; 2017 May; 66(5):1012-1021. PubMed ID: 28088579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.